37. PRELIMINARY EVALUATION OF THE EFFECTIVENESS OF THE MULTIDISCIPLINARY MANAGEMENT PROTOCOL FOR ANTIHYPERTENSIVE MEDICATIONS ON THE DAY OF SCHEDULED SURGERY

Phan Ton Ngoc Vu1, Vo Lan Phuong1
1 Ho Chi Minh City University of Medicine and Pharmacy Hospital

Main Article Content

Abstract

Objectives: The first objective is to assess the discontinuation rate of antihypertensive medications on the day of scheduled surgery. The second objective is to compare medication continuation rates before and after implementing a coordinated management protocol.


Materials and methods: Adult hypertensive patients scheduled for surgery were divided into two groups. An observational study evaluated the first objective, while an interventional study addressed the second.


Results: The observational study included 121 patients and reported that 39.7% continued their antihypertensive medications on the day of scheduled surgery. In the control group, which included 34 patients before the implementation of the protocol, 67.6% continued their medication. In the intervention group, which comprised 30 patients post-implementation, the continuation rate was 86.7% (p=0.073).


Conclusions: The discontinuation of antihypertensive medications on the day of scheduled surgery remains prevalent. Implementing a multidisciplinary management protocol for antihypertensive medications could potentially improve the continuation rates of these medications on the day of scheduled surgeries.

Article Details

References

[1] Bilimoria KY, Liu Y, Paruch JL, et al. Development and evaluation of the universal ACS NSQIP surgical risk calculator: a decision aid and informed consent tool for patients and surgeons. J Am Coll Surg. Nov 2013;217(5):833-42 e1-3.
[2] Aronow WS. Management of hypertension in patients undergoing surgery. Ann Transl Med. May 2017;5(10):227.
[3] Ko CY, Hall BL, Hart AJ, Cohen ME, Hoyt DB. The American College of Surgeons National Surgical Quality Improvement Program: achieving better and safer surgery. Jt Comm J Qual Patient Saf. May 2015;41(5):199-204.
[4] Lilja M, Jounela AJ, Juustila H. Withdrawal syndromes and the cessation of antihypertensive therapy. Arch Intern Med. Apr 1982;142(4):839- 40.
[5] Mancia G, Kreutz R, Brunstrom M, et al. 2023 ESH Guidelines for the management of arterial hypertension The Task Force for the management of arterial hypertension of the European Society of Hypertension: Endorsed by the International Society of Hypertension (ISH) and the European Renal Association (ERA). J Hypertens. Dec 1 2023;41(12):1874-2071.